Citation only
via OpenAlex
P2‐301: The mTOR pathway in Alzheimer's disease
Alzheimer s & Dementia · 2011
Abstract
Getting beyond old models of pathogenesis is an important part of Alzheimer's research today. Cell cycle re-entry and subsequent regulatory failure at the G1/S transition is an early event in the pathogenesis of Alzheimer's disease (AD). Vulnerable neuronal populations enter the cell cycle and progress as far as the late G2 phase and accumulate the Alzheimer-type pathology. In order to further dissect the molecular pathways involved in AD, we have performed gene expression studies in human brain tissues from AD patients and controls. We have found that the G1/S regulatory failure is associated with a deregulation of the mTOR(definition) pathway in AD patients. mTOR is a serine/threonine protein kinase that regulates cell growth and proliferation in response to growth and stress signals. The inhibition of the pathway by Rapamycin(definition), an FDA approved drug, has been shown to extend lifespan, cellular senescence(definition), and more recently reduce AD-type pathology in rodent models of AD. We now find that the molecular dissection of the mTOR response pathway in AD identifies novel therapeutic targets and opens the possibility of developing new blood based biomarkers for the disease. Our findings also further the literature to suggest that Rapamycin may be of therapeutic value to prevent neurodegeneration in Alzheimer's disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.jalz.2011.05.1179
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
Nagy, Z. (2011). P2‐301: The mTOR pathway in Alzheimer's disease. <em>Alzheimer s & Dementia</em>. https://doi.org/10.1016/j.jalz.2011.05.1179
Vancouver
Nagy Z. P2‐301: The mTOR pathway in Alzheimer's disease. Alzheimer s & Dementia. 2011. doi:10.1016/j.jalz.2011.05.1179.
BibTeX
@article{zsuzsanna2011PThemT,
title = {P2‐301: The mTOR pathway in Alzheimer's disease},
author = {Zsuzsanna Nagy},
journal = {Alzheimer s & Dementia},
year = {2011},
doi = {10.1016/j.jalz.2011.05.1179},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Neuropsychologia 2020
Preprint · OA
Beyond Alzheimer's disease: Can bilingualism be a more generalized protective factor in neurodegeneration?
BioMed Research International 2014
Open access · CC-BY
Resveratrol as a Therapeutic Agent for Alzheimer’s Disease
CRC Press eBooks 2005
Citation only
Oxidative Stress and Age-Related Neurodegeneration
Bratislavské lekárske listy/Bratislava medical journal 2006
Citation only
The role of oxidative stress in the pathogenesis of Alzheimer's disease
Brain 2012
Open access · CC-BY
Suppression of protein aggregation by chaperone modification of high molecular weight complexes
British Journal of Clinical Pharmacology 2016
Preprint · OA